✦ LIBER ✦

Immunodensity and mRNA expression of A2Aadenosine, D2dopamine, and CB1cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment

✍ Scribed by Leyre Urigüen; M. Julia García-Fuster; Luis F. Callado; Benito Morentin; Romano La Harpe; Vicent Casadó; Carmen Lluis; Rafael Franco; Jesús A. García-Sevilla; J. Javier Meana

Publisher: Springer
Year: 2009
Tongue: English
Weight: 271 KB
Volume: 206
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-009-1608-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AVE1625, a cannabinoid CB1 receptor anta

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

✍ Mark D. Black; Rachel J. Stevens; Nancy Rogacki; Robert E. Featherstone; Yaw Sen 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 420 KB

Enhancement of antipsychotic-like effect

Enhancement of antipsychotic-like effects by combined treatment with the α1-adrenoceptor antagonist prazosin and the dopamine D2receptor antagonist raclopride in rats

✍ M.-L. Wadenberg; P. Hertel; R. Fernholm; K. Hygge Blakeman; S. Ahlenius; T. H. S 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 103 KB